Metalloproteinase inhibitors and the prevention of connective tissue breakdown.
about
Structure of amidase from Pseudomonas aeruginosa showing a trapped acyl transfer reaction intermediate stateCorneal cell proteins and ocular surface pathologyInflammatory effects of snake venom metalloproteinasesEsculetin inhibits cartilage resorption induced by interleukin 1alpha in combination with oncostatin MInsulin-like growth factor 1 blocks collagen release and down regulates matrix metalloproteinase-1, -3, -8, and -13 mRNA expression in bovine nasal cartilage stimulated with oncostatin M in combination with interleukin 1alphaMatrix metalloproteinase expression and inhibition after sciatic nerve axotomy.Design and synthetic considerations of matrix metalloproteinase inhibitors.Acyl transfer activity of an amidase from Rhodococcus sp. strain R312: formation of a wide range of hydroxamic acids.Novel approaches and targets for treatment of chronic obstructive pulmonary disease.Proteolysis in human breast cancer.Novel therapy for COPD.Aliphatic and enantioselective amidases: from hydrolysis to acyl transfer activity.Mesenchymal stem cell stimulation of tissue growth depends on differentiation state.Role of metalloelastase in a model of allergic lung responses induced by cockroach allergen.Biomarkers for identifying the early phases of osteoarthritis secondary to medial patellar luxation in dogsCell surface collagenolysis requires homodimerization of the membrane-bound collagenase MT1-MMPMatrix metalloproteinases and their inhibitors in gastric cancer.Inhibition of type I procollagen synthesis by damaged collagen in photoaged skin and by collagenase-degraded collagen in vitroGene therapy for chronic obstructive pulmonary disease: twilight or triumph?Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study.Application of biomarkers in the clinical development of new drugs for chondroprotection in destructive joint diseases: a review.Midtrimester amniotic fluid matrix metalloproteinase-8 (MMP-8) levels above the 90th percentile are a marker for subsequent preterm premature rupture of membranes.MMP inhibition as a potential method to augment the healing of skeletal muscle and tendon extracellular matrix.Luteolin suppresses UVB-induced photoageing by targeting JNK1 and p90 RSK2.Matrix metalloproteinases in recurrent corneal melting associated with primary Sjörgen's syndrome.Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis.Developments in drugs for the treatment of chronic obstructive pulmonary disease.Impact of matrix metalloproteinases on inhibition of mineralization by fetuin.Plantamajoside Inhibits UVB and Advanced Glycation End Products-Induced MMP-1 Expression by Suppressing the MAPK and NF-κB Pathways in HaCaT Cells.Effects of Medical Chitosan on Capsular Formation Following Silicone Implant Insertion in a Rabbit Model.Human protein kinase CK2 phosphorylates matrix metalloproteinase 2 and inhibits its activity.The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: a time-course study using real-time quantitative reverse transcription-polymerase chain reaction.Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines.Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis.Adenoviral gene transfer of interleukin-1 in combination with oncostatin M induces significant joint damage in a murine model.Implication of interleukin 18 in production of matrix metalloproteinases in articular chondrocytes in arthritis: direct effect on chondrocytes may not be pivotalCrystal structure of an active form of human MMP-1.Solution structures of stromelysin complexed to thiadiazole inhibitors.Synovial tissue protease gene expression and joint erosions in early rheumatoid arthritis.The collagenolytic action of MMP-1 is regulated by the interaction between the catalytic domain and the hinge region.
P2860
Q27644498-ED26349E-EE22-4B3F-A337-FA742DC85EFDQ28140384-D84F3364-CFC8-4582-BFC1-45AD290B284DQ28257193-3795A965-E530-443A-B1E5-D5BAEB1840AEQ28345787-E4D80A9A-0451-4440-BE60-0D4F6D9DF948Q28348472-977361EA-C96B-4AFB-94D0-D0303FF84438Q32001558-70FFD604-0B85-488A-BE40-B4F0F1A2C325Q33692904-FCC5DCBA-CDFF-4E5C-8077-E83C1B409593Q33721317-28667D8F-6DC0-4DC5-9B58-B636DEAF6E4BQ33771480-73FCF970-1CD2-4DC8-B58D-63FF3BA0E087Q33918458-F62B691E-496A-401E-A4CA-B51121CF3ACCQ34074654-430D7831-1DE9-45F2-9272-E5CF7A90077AQ34369647-2D88DD78-05C8-4ED8-8D69-99A1D1DC6E20Q35084097-9F7C1068-65A2-46DC-BDE5-505E6DAD8A27Q35103534-801471AD-9CF1-4D96-A141-BE60D952FE64Q35190913-B2F4E593-34A0-4D04-9F1C-ACE355D69CE6Q35191039-3DC62BD9-8A56-4953-8791-95CA6154404AQ35353488-590E5AD7-741B-4E38-AA38-0BF2995EC7FAQ35746471-383004B0-6A18-4706-9DBA-0862AF0805F0Q36099456-3D136A66-7F80-4E63-9438-AE6957510908Q36401915-81278A59-945D-41B2-8E57-8D81E2B52468Q36631211-F878EF13-4C59-44F4-971D-5D56876A0AFBQ37040946-0DF84363-6888-498E-A9BC-DD36E058B273Q37150778-611F950A-3B22-4072-BD9A-9F108B51242DQ37294568-0FA31C4F-D76C-47F0-AE9E-FADDB0E8B6F4Q37425263-EF6829A0-84F8-4A4D-93F7-3CE665EFA542Q37491625-3B4BA59D-1753-4133-A4DE-AF3E817F3513Q37754541-0CE56E47-E7EE-4895-AF1A-2F7323221BE6Q38051442-F74D8140-4FC6-43B7-B51F-7386B887A1B3Q38761817-AB3194DD-455E-4052-958B-4B51A3A78766Q38865441-2BE1D391-3778-4419-BEA1-5A6BCCFB4481Q38973538-3671DD8F-5B08-4197-B552-D6699DC8B897Q40738183-6D56954C-EBD8-4DA3-B6B6-DEED4EC319A9Q41866942-B9F98D14-1763-4B4E-BA8D-3ECA20A7F7F9Q41962820-92E668DA-1F59-4C67-A23F-24D3FF5FDA44Q42047774-43C5590D-4C4C-4321-8EC5-6CB6EDDE0FEFQ42099571-9BD4107D-6B87-4954-872D-6E46BF6E817BQ42756684-078949EA-2AEB-4869-8F63-DEABDFCB1349Q42846171-0C9C6624-E10B-4590-A96E-26BC5055BDBFQ43709155-E321F719-80C9-4E58-9C18-75F134F1306AQ44506060-3266FC3C-5CC7-4BB3-80B9-07CF1DCB4E3C
P2860
Metalloproteinase inhibitors and the prevention of connective tissue breakdown.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Metalloproteinase inhibitors and the prevention of connective tissue breakdown.
@en
type
label
Metalloproteinase inhibitors and the prevention of connective tissue breakdown.
@en
prefLabel
Metalloproteinase inhibitors and the prevention of connective tissue breakdown.
@en
P1476
Metalloproteinase inhibitors and the prevention of connective tissue breakdown.
@en
P2093
Cawston TE
P304
P356
10.1016/0163-7258(96)00015-0
P577
1996-01-01T00:00:00Z